Clinical Trial Update: Real-World Efgartigimod Effectiveness in CIDP: A Prospective Study

View source ↗

Summary

A prospective real-world study is investigating the effectiveness of efgartigimod in CIDP and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Demyelinating Polyradiculoneuropathy

Drugs mentioned

• VYVGART (EFGARTIGIMOD ALFA)

Snippet

Sponsor: argenx | Conditions: Chronic Inflammatory Demyelinating Polyradiculoneuropathy, CIDP | Status: RECRUITING